INS018_055

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INS018_055, covering 2025-11-12 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]